Interactive Investor
>>

AVITA Medical Inc (NASDAQ:RCEL) Share Price

RCEL

AVITA Medical Inc

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Medical Devices

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centres. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to gain approval and launch in Japan via distribution partner Cosmotec shortly. Avita is domiciled, and has its primary listing, in the U.S.Avita Medical Ltd is engaged in developing and distributing regenerative products for the treatment of a range of wounds, scars, and skin defects. The company’s lead product ReCell is used in the treatment of a variety of burns, plastic, and others.

NASDAQ:RCEL

US05380C1027

USD

Loading...

Loading Comparison

Latest RCEL News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News